[Finerenone (CKD stage 3 and 4) – Addendum to Commission A23-15]

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018005117
Original Title: Finerenon (Niereninsuffizienz, Stadium 3 und 4) - Addendum zum Projekt A23-15 (Dossierbewertung)
Project Status: Completed
Year Published: 2023
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
MeSH Terms
  • Renal Insufficiency, Chronic
  • Diabetes Mellitus, Type 2
  • Naphthyridines
  • Finerenone
  • Renal Insufficiency – Chronic
  • Diabetes Mellitus – Type 2
  • Benefit Assessment
  • NCT02545049
  • NCT02540993
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: <p>Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.